Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03826420
Recruitment Status : Not yet recruiting
First Posted : February 1, 2019
Last Update Posted : March 11, 2019
Sponsor:
Collaborators:
Pennsylvania Department of Corrections
Bureau of Justice Assistance
Information provided by (Responsible Party):
Botec Analysis, LLC

Tracking Information
First Submitted Date  ICMJE January 30, 2019
First Posted Date  ICMJE February 1, 2019
Last Update Posted Date March 11, 2019
Estimated Study Start Date  ICMJE April 1, 2019
Estimated Primary Completion Date August 15, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: February 7, 2019)
Revocation Rate [ Time Frame: 9 Months ]
Percentage of subjects in each condition who are revoked from parole and returned to prison
Original Primary Outcome Measures  ICMJE
 (submitted: January 30, 2019)
Revocation Rate [ Time Frame: 12 Months ]
Percentage of subjects in each condition who are revoked from parole and returned to prison
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: February 7, 2019)
  • Days Incarcerated [ Time Frame: 9 Months ]
    Total number of days incarcerated in jail or prison per parolee
  • New Charges [ Time Frame: 9 Months ]
    Number of new charges per parolee
  • Percent Positive Drug Tests [ Time Frame: 9 Months ]
    Percentage of random and scheduled drug tests that result in a positive reading for illicit drugs
Original Secondary Outcome Measures  ICMJE
 (submitted: January 30, 2019)
  • Days Incarcerated [ Time Frame: 12 Months ]
    Total number of days incarcerated in jail or prison
  • New Charges [ Time Frame: 12 Months ]
    Number of new charges
  • Percent Positive Drug Tests [ Time Frame: 12 Months ]
    Percentage of random and scheduled drug tests that test positive for illicit drugs
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole
Official Title  ICMJE Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole
Brief Summary

This research project will study the outcomes of medium- to high-risk parolees with a history of substance abuse in Alleghany County, Pennsylvania supervised under Swift-Certain-Fair parole.

The research goals are to:

  • Determine the effectiveness of SCF parole in reducing recidivism among medium- to high-risk parolees with a history of substance abuse in Pennsylvania.
  • Determine the minimum effective sanction in response to a violation that will bring parolees into compliance with the conditions of their parole.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description:
Participants (parolees) will not be notified as to which arm they are enrolled.
Primary Purpose: Prevention
Condition  ICMJE
  • Substance Abuse
  • Criminal Behavior
Intervention  ICMJE
  • Behavioral: SCF Supervision with Secure Confinement Sanctioning
    Parolees assigned to this group will, in the face of a violation, be given a sanction that involves secure confinement.
  • Behavioral: SCF Supervision with Work Release Sanctioning
    Parolees assigned to this group will, in the face of a violation, be given a sanction that involves work-release.
  • Behavioral: SCF Supervision with GPS Supervision Sanctioning
    Parolees assigned to this group will, in the face of a violation, be given a sanction that involves GPS supervision.
Study Arms  ICMJE
  • Experimental: Secure Confinement Group
    Parolees assigned to this group will be assigned sanctions that include secure confinement.
    Intervention: Behavioral: SCF Supervision with Secure Confinement Sanctioning
  • Experimental: Work Release Group
    Parolees assigned to this group will be assigned sanctions that include work-release.
    Intervention: Behavioral: SCF Supervision with Work Release Sanctioning
  • Experimental: GPS Supervision Group
    Parolees assigned to this group will be assigned sanctions that include GPS supervision.
    Intervention: Behavioral: SCF Supervision with GPS Supervision Sanctioning
  • No Intervention: Control Group
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: January 30, 2019)
250
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 31, 2020
Estimated Primary Completion Date August 15, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Assigned to the Pittsburgh District
  • Allegheny County resident
  • Has at least 2 years left on supervision
  • Had a prior drug or alcohol related sanction

Exclusion Criteria:

  • Sex offender
  • Reentrants assigned to the Special Needs Unit
Sex/Gender  ICMJE
Sexes Eligible for Study: Male
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE
Contact: Clarissa Manning (424) 262-8064 clarissa.manning@botecanalysis.com
Listed Location Countries  ICMJE Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03826420
Other Study ID Numbers  ICMJE BOTEC PADOC SCF
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Undecided
Responsible Party Botec Analysis, LLC
Study Sponsor  ICMJE Botec Analysis, LLC
Collaborators  ICMJE
  • Pennsylvania Department of Corrections
  • Bureau of Justice Assistance
Investigators  ICMJE
Principal Investigator: Mark AR Kleiman BOTEC Analysis
PRS Account Botec Analysis, LLC
Verification Date March 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP